DBV Technologies S.A. (NASDAQ:DBVT - Get Free Report)'s stock price crossed below its 50 day moving average during trading on Tuesday . The stock has a 50 day moving average of $3.37 and traded as low as $2.99. DBV Technologies shares last traded at $3.09, with a volume of 24,330 shares changing hands.
Analyst Upgrades and Downgrades
A number of equities analysts have recently weighed in on DBVT shares. JMP Securities reissued a "market outperform" rating and set a $10.00 price target on shares of DBV Technologies in a research report on Tuesday, December 10th. StockNews.com began coverage on DBV Technologies in a report on Wednesday. They set a "hold" rating on the stock. Finally, HC Wainwright increased their price target on DBV Technologies from $25.00 to $35.00 and gave the stock a "buy" rating in a report on Thursday, October 24th.
View Our Latest Analysis on DBVT
DBV Technologies Price Performance
The company's 50-day moving average price is $3.36 and its 200-day moving average price is $3.87. The company has a market cap of $63.56 million, a P/E ratio of -0.69 and a beta of 0.64.
About DBV Technologies
(
Get Free Report)
DBV Technologies SA, a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its product pipeline comprising Viaskin Peanut, an immunotherapy product, which has completed Phase 3 clinical trial for the treatment of peanut allergies; and Viaskin Milk which is in Phase 1/2 clinical trial for the treatment of immunoglobulin E (IgE) mediated or cow's milk protein allergy and eosinophilic esophagitis.
Recommended Stories
Before you consider DBV Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DBV Technologies wasn't on the list.
While DBV Technologies currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
